Ultimovacs ASA Reports Second Quarter 2023 Financial Results and Provides General Business Update
Oslo, 22 August 2023: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology leader in novel immunotherapeutic cancer vaccines, announces its...